Invesco Pharmaceuticals ETF
PJP
PJP
93 hedge funds and large institutions have $75.6M invested in Invesco Pharmaceuticals ETF in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.18% more ownership
Funds ownership: 22.83% → 23.01% (+0.18%)
Holders
93
Holding in Top 10
–
Calls
$377K
Puts
–
Top Buyers
| 1 | +$3.36M | |
| 2 | +$3.3M | |
| 3 | +$1.43M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.2M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$746K |
Top Sellers
| 1 | -$8.29M | |
| 2 | -$1.41M | |
| 3 | -$976K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$443K |
| 5 |
Goldman Sachs
New York
|
-$328K |